Fuli Shi

581 total citations
20 papers, 421 citations indexed

About

Fuli Shi is a scholar working on Molecular Biology, Nephrology and Rheumatology. According to data from OpenAlex, Fuli Shi has authored 20 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Nephrology and 4 papers in Rheumatology. Recurrent topics in Fuli Shi's work include Inflammasome and immune disorders (6 papers), Heterotopic Ossification and Related Conditions (4 papers) and Parathyroid Disorders and Treatments (4 papers). Fuli Shi is often cited by papers focused on Inflammasome and immune disorders (6 papers), Heterotopic Ossification and Related Conditions (4 papers) and Parathyroid Disorders and Treatments (4 papers). Fuli Shi collaborates with scholars based in China, United Kingdom and Taiwan. Fuli Shi's co-authors include Hui Lin, Ying Ying, Dong‐Yun Ouyang, Rong Xu, Xian‐Hui He, Qingbing Zha, Lingyu Luo, Shuping Jiang, Deqiang Huang and Zhijun Luo and has published in prestigious journals such as Frontiers in Immunology, International Journal of Biological Macromolecules and Journal of Cellular Biochemistry.

In The Last Decade

Fuli Shi

18 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fuli Shi China 12 262 83 59 52 52 20 421
Maha E. Houssen Egypt 13 130 0.5× 102 1.2× 64 1.1× 76 1.5× 35 0.7× 27 455
Qingchun Diao China 13 159 0.6× 66 0.8× 29 0.5× 42 0.8× 40 0.8× 37 436
Lixia Bai China 13 279 1.1× 67 0.8× 45 0.8× 30 0.6× 71 1.4× 28 538
Guanqun Xie China 12 130 0.5× 89 1.1× 26 0.4× 63 1.2× 40 0.8× 27 356
Xiaojuan Feng China 15 219 0.8× 121 1.5× 30 0.5× 72 1.4× 75 1.4× 27 501
Harrison M. Penrose United States 12 220 0.8× 59 0.7× 62 1.1× 17 0.3× 79 1.5× 22 473
Hui‐Li Lin Taiwan 13 169 0.6× 59 0.7× 55 0.9× 30 0.6× 50 1.0× 28 432
Paulina Hennig Switzerland 9 366 1.4× 119 1.4× 86 1.5× 29 0.6× 32 0.6× 16 487
Eirini Konstantinidou United States 3 226 0.9× 99 1.2× 71 1.2× 13 0.3× 75 1.4× 6 485

Countries citing papers authored by Fuli Shi

Since Specialization
Citations

This map shows the geographic impact of Fuli Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuli Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuli Shi more than expected).

Fields of papers citing papers by Fuli Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuli Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuli Shi. The network helps show where Fuli Shi may publish in the future.

Co-authorship network of co-authors of Fuli Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Fuli Shi. A scholar is included among the top collaborators of Fuli Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuli Shi. Fuli Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Yan, Xiuwen Liang, Lingzhi Wang, et al.. (2025). Impaired NLRP3 inflammasome signaling diverts pyroptotic to apoptotic caspase activation in macrophages. Frontiers in Immunology. 16. 1631152–1631152.
2.
Lu, Na, Qing Li, Rong Xu, et al.. (2025). Andrographolide prevents necroptosis by suppressing the generation of reactive oxygen species. Acta Biochimica et Biophysica Sinica. 57(12). 2048–2061. 1 indexed citations
3.
Wan, Yiqi, et al.. (2025). Dysfunctional circadian-driven dynamics in gut microbiota and tumor microenvironment. Gut Microbes. 17(1). 2526716–2526716.
4.
Shi, Fuli, Qing Li, Yaping Li, et al.. (2023). Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis. Pharmacological Research. 189. 106697–106697. 43 indexed citations
5.
Li, Qing, Ying Chen, Fuli Shi, et al.. (2023). Anti-Necroptotic Effects of Itaconate and its Derivatives. Inflammation. 47(1). 285–306. 4 indexed citations
6.
Shi, Fuli, Qing Li, Rong Xu, et al.. (2023). Blocking reverse electron transfer-mediated mitochondrial DNA oxidation rescues cells from PANoptosis. Acta Pharmacologica Sinica. 45(3). 594–608. 35 indexed citations
7.
Shi, Fuli, Bo Hu, Rong Xu, et al.. (2022). Dimethyl fumarate ameliorates autoimmune hepatitis in mice by blocking NLRP3 inflammasome activation. International Immunopharmacology. 108. 108867–108867. 32 indexed citations
8.
Zhang, Hongrui, Siyuan Chen, Lihui Xu, et al.. (2022). Baicalin inhibits necroptosis by decreasing oligomerization of phosphorylated MLKL and mitigates caerulein-induced acute pancreatitis in mice. International Immunopharmacology. 108. 108885–108885. 34 indexed citations
9.
Shi, Fuli, Zhimin Tang, Shanshan Jiang, et al.. (2022). AMP‐activated protein kinase β1 or β2 deletion enhances colon cancer cell growth and tumorigenesis. Acta Biochimica et Biophysica Sinica. 54(8). 1140–1147. 2 indexed citations
10.
Zeng, Bo, Siyuan Chen, Rong Xu, et al.. (2022). Dextran sodium sulfate potentiates NLRP3 inflammasome activation by modulating the KCa3.1 potassium channel in a mouse model of colitis. Cellular and Molecular Immunology. 19(8). 925–943. 50 indexed citations
11.
Xu, Rong, Siying Liu, Bo Hu, et al.. (2021). Taraxasterol mitigates Con A-induced hepatitis in mice by suppressing interleukin-2 expression and its signaling in T lymphocytes. International Immunopharmacology. 102. 108380–108380. 11 indexed citations
12.
Liu, Ting, et al.. (2020). Mouse model of menstruation: An indispensable tool to investigate the mechanisms of menstruation and gynaecological diseases (Review). Molecular Medicine Reports. 22(6). 4463–4474. 12 indexed citations
13.
Lin, Hui, Fuli Shi, Shanshan Jiang, et al.. (2020). Metformin attenuates trauma‐induced heterotopic ossification via inhibition of Bone Morphogenetic Protein signalling. Journal of Cellular and Molecular Medicine. 24(24). 14491–14501. 15 indexed citations
14.
Jiang, Shuping, Fuli Shi, Hui Lin, et al.. (2019). Inonotus obliquus polysaccharides induces apoptosis of lung cancer cells and alters energy metabolism via the LKB1/AMPK axis. International Journal of Biological Macromolecules. 151. 1277–1286. 54 indexed citations
15.
Shi, Fuli, Jiayu Gao, Junrong Zou, Ying Ying, & Hui Lin. (2019). Targeting heterotopic ossification by inhibiting activin receptor‑like kinase 2 function (Review). Molecular Medicine Reports. 20(4). 2979–2989. 3 indexed citations
16.
Ren, Bowen, et al.. (2019). BMP and mTOR signaling in heterotopic ossification: Does their crosstalk provide therapeutic opportunities?. Journal of Cellular Biochemistry. 120(8). 12108–12122. 25 indexed citations
17.
Lin, Hui, Fuli Shi, Jiayu Gao, & Ping Hua. (2019). The role of Activin A in fibrodysplasia ossificans progressiva: a prominent mediator. Bioscience Reports. 39(8). 8 indexed citations
18.
Jiang, Shanshan, Yan Wang, Lingyu Luo, et al.. (2019). AMP‐activated protein kinase regulates cancer cell growth and metabolism via nuclear and mitochondria events. Journal of Cellular and Molecular Medicine. 23(6). 3951–3961. 32 indexed citations
19.
Sun, Ruipu, Ying Ying, Zhimin Tang, et al.. (2019). The Emerging Role of the SLCO1B3 Protein in Cancer Resistance. Protein and Peptide Letters. 27(1). 17–29. 20 indexed citations
20.
Zhu, Na, Ruipu Sun, Wangdi Liao, et al.. (2018). Metformin Inhibits Chemokine Expression Through the AMPK/NF-κB Signaling Pathway. Journal of Interferon & Cytokine Research. 38(9). 363–369. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026